Medical devices industry venture financing deals in December 2019 total $1.19bn globally

28 January 2020 (Last Updated January 28th, 2020 14:11)

Medical devices industry venture financing deals in December 2019 total $1.19bn globally

Total medical devices industry venture financing deals in December 2019 worth $1.19bn were announced globally, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked an increase of 5% over the previous month and a rise of 43.3% when compared with the last 12-month average, which stood at $830.75m.

Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $769.57m. At the country level, the US topped the list in terms of deal value at $769.28m.

In terms of volumes, North America emerged as the top region for medical devices industry venture financing deals globally, followed by Europe and then Asia-Pacific.

The top country in terms of venture financing deals activity in December 2019 was the US with 50 deals, followed by China with nine and Switzerland with seven.

In 2019, as of the end of December 2019, medical devices venture financing deals worth $10.57bn were announced globally, marking an increase of 9.5% year on year.

Medical devices industry venture financing deals in December 2019: Top deals

The top five medical devices industry venture financing deals accounted for 41.1% of the overall value during December 2019.

The combined value of the top five medical devices venture financing deals stood at $489.64m, against the overall value of $1.19bn recorded for the month.

The top five medical devices industry deals of December 2019 tracked by GlobalData were:

1) Foresite Capital Management, JS Capital Management, Merieux Developpement, MLS Capital Fund II, NanoDimension Management, Oak HC/FT Partners, Paladin Capital Group and Venrock’s $125m venture financing of Inscripta

2) The $114.39m venture financing of Geneseeq Technology by China ReformLtd, Lilly Asia ventures and Softbank China Venture Capital

3) 3H Health Investment, Ally Bridge Group, Ascension Ventures, Bain Capital Life Sciences, Delos Capital, Incept and Rock Springs Capital Management’s $85m venture financing of Imperative Care

4) The $85m venture financing of Sonendo by ArrowMark Partners, Broadfin Capital, CVF, Essex Woodlands Management, General Atlantic, JMR Capital, Meritech Capital Partners, NeoMed Management, Orbimed Advisors, Perceptive Advisors, Redmile Group, SEB Private Equity and Security Pacific Finance

5) Abiomed, Acorn Bioventures, Amzak Health, Kennedy Lewis Investment Management, Minth Investment, Wellington ManagementLLP and Zoll Medical’s venture financing of Impulse Dynamics for $80.25m.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.